JPS591258B2 - ジフエニルスルホキシド誘導体の製造方法 - Google Patents
ジフエニルスルホキシド誘導体の製造方法Info
- Publication number
- JPS591258B2 JPS591258B2 JP50117346A JP11734675A JPS591258B2 JP S591258 B2 JPS591258 B2 JP S591258B2 JP 50117346 A JP50117346 A JP 50117346A JP 11734675 A JP11734675 A JP 11734675A JP S591258 B2 JPS591258 B2 JP S591258B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- acid
- mol
- ether
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- JJHHIJFTHRNPIK-UHFFFAOYSA-N Diphenyl sulfoxide Chemical class C=1C=CC=CC=1S(=O)C1=CC=CC=C1 JJHHIJFTHRNPIK-UHFFFAOYSA-N 0.000 title claims 3
- 239000002253 acid Substances 0.000 claims description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 11
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- -1 diphenyl sulfonate derivatives Chemical class 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000003610 charcoal Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012954 diazonium Substances 0.000 description 3
- 150000001989 diazonium salts Chemical class 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- XUSKZLBLGHBCLD-UHFFFAOYSA-N 2-(3-aminophenyl)acetic acid Chemical compound NC1=CC=CC(CC(O)=O)=C1 XUSKZLBLGHBCLD-UHFFFAOYSA-N 0.000 description 2
- XXVHRCGOMXELOK-UHFFFAOYSA-N 2-(3-phenylsulfanylphenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(SC=2C=CC=CC=2)=C1 XXVHRCGOMXELOK-UHFFFAOYSA-N 0.000 description 2
- CSEWAUGPAQPMDC-UHFFFAOYSA-N 2-(4-aminophenyl)acetic acid Chemical compound NC1=CC=C(CC(O)=O)C=C1 CSEWAUGPAQPMDC-UHFFFAOYSA-N 0.000 description 2
- NUTKILCVRNZYKY-UHFFFAOYSA-N CC(C(=O)O)C1=CC(=CC=C1)SC1=CC=CC=C1 Chemical compound CC(C(=O)O)C1=CC(=CC=C1)SC1=CC=CC=C1 NUTKILCVRNZYKY-UHFFFAOYSA-N 0.000 description 2
- GUUVPOWQJOLRAS-UHFFFAOYSA-N Diphenyl disulfide Chemical compound C=1C=CC=CC=1SSC1=CC=CC=C1 GUUVPOWQJOLRAS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- AZFNGPAYDKGCRB-XCPIVNJJSA-M [(1s,2s)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1-methyl-4-propan-2-ylbenzene Chemical compound [Ru+]Cl.CC(C)C1=CC=C(C)C=C1.C1=CC(C)=CC=C1S(=O)(=O)[N-][C@@H](C=1C=CC=CC=1)[C@@H](N)C1=CC=CC=C1 AZFNGPAYDKGCRB-XCPIVNJJSA-M 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000004304 potassium nitrite Substances 0.000 description 2
- 235000010289 potassium nitrite Nutrition 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- KTBYLBDUVMGLPP-UHFFFAOYSA-N 2-[3-(benzenesulfinyl)phenyl]acetic acid Chemical compound C1(=CC=CC=C1)S(=O)C=1C=C(C=CC1)CC(=O)O KTBYLBDUVMGLPP-UHFFFAOYSA-N 0.000 description 1
- CKQHAYFOPRIUOM-UHFFFAOYSA-N 3'-Aminoacetophenone Chemical compound CC(=O)C1=CC=CC(N)=C1 CKQHAYFOPRIUOM-UHFFFAOYSA-N 0.000 description 1
- 241001237754 Algia Species 0.000 description 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000035859 Drug effect increased Diseases 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- ZGUNAGUHMKGQNY-UHFFFAOYSA-N alpha-phenylglycine Chemical compound OC(=O)C(N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- OTGHWLKHGCENJV-UHFFFAOYSA-N glycidic acid Chemical compound OC(=O)C1CO1 OTGHWLKHGCENJV-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
- C07C43/295—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4238774A GB1519147A (en) | 1974-09-30 | 1974-09-30 | Sulphur and oxygen-containing diaryl compounds |
| GB4238774 | 1974-09-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5163146A JPS5163146A (enExample) | 1976-06-01 |
| JPS591258B2 true JPS591258B2 (ja) | 1984-01-11 |
Family
ID=10424196
Family Applications (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50117346A Expired JPS591258B2 (ja) | 1974-09-30 | 1975-09-30 | ジフエニルスルホキシド誘導体の製造方法 |
| JP50117347A Granted JPS51125228A (en) | 1974-09-30 | 1975-09-30 | Preparation of diaryl compounds |
| JP50117344A Pending JPS51125237A (en) | 1974-09-30 | 1975-09-30 | Preparation of sulfurrcontaining arylamine derivative |
| JP50117345A Expired JPS5820954B2 (ja) | 1974-09-30 | 1975-09-30 | フエニルスルフイニルユウドウタイ ノ セイゾウホウホウ |
| JP59115620A Granted JPS6034935A (ja) | 1974-09-30 | 1984-06-07 | ジアリ−ル化合物の製造方法 |
| JP59115619A Granted JPS6110524A (ja) | 1974-09-30 | 1984-06-07 | ジアリ−ル化合物の製造方法 |
| JP59115621A Pending JPS6034939A (ja) | 1974-09-30 | 1984-06-07 | ジアリ−ル化合物の製造方法 |
| JP59139795A Pending JPS60231628A (ja) | 1974-09-30 | 1984-07-07 | ジアリ−ル化合物の製造方法 |
| JP59139796A Pending JPS60248656A (ja) | 1974-09-30 | 1984-07-07 | ジアリ−ル化合物の製造方法 |
| JP59139794A Granted JPS60231648A (ja) | 1974-09-30 | 1984-07-07 | ジアリ−ル化合物の製造方法 |
Family Applications After (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50117347A Granted JPS51125228A (en) | 1974-09-30 | 1975-09-30 | Preparation of diaryl compounds |
| JP50117344A Pending JPS51125237A (en) | 1974-09-30 | 1975-09-30 | Preparation of sulfurrcontaining arylamine derivative |
| JP50117345A Expired JPS5820954B2 (ja) | 1974-09-30 | 1975-09-30 | フエニルスルフイニルユウドウタイ ノ セイゾウホウホウ |
| JP59115620A Granted JPS6034935A (ja) | 1974-09-30 | 1984-06-07 | ジアリ−ル化合物の製造方法 |
| JP59115619A Granted JPS6110524A (ja) | 1974-09-30 | 1984-06-07 | ジアリ−ル化合物の製造方法 |
| JP59115621A Pending JPS6034939A (ja) | 1974-09-30 | 1984-06-07 | ジアリ−ル化合物の製造方法 |
| JP59139795A Pending JPS60231628A (ja) | 1974-09-30 | 1984-07-07 | ジアリ−ル化合物の製造方法 |
| JP59139796A Pending JPS60248656A (ja) | 1974-09-30 | 1984-07-07 | ジアリ−ル化合物の製造方法 |
| JP59139794A Granted JPS60231648A (ja) | 1974-09-30 | 1984-07-07 | ジアリ−ル化合物の製造方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US4065584A (enExample) |
| JP (10) | JPS591258B2 (enExample) |
| BE (4) | BE833580A (enExample) |
| CA (2) | CA1040206A (enExample) |
| CH (3) | CH602618A5 (enExample) |
| DE (3) | DE2543252C2 (enExample) |
| FR (3) | FR2285867A1 (enExample) |
| IE (3) | IE41724B1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4098824A (en) * | 1975-10-02 | 1978-07-04 | Laboratoire L. Lafon | Benzhydrylsulphinyl derivatives |
| DE2611695A1 (de) * | 1976-03-19 | 1977-09-29 | Hoechst Ag | Herbizide mittel |
| GB1574822A (en) * | 1976-03-23 | 1980-09-10 | Lafon Labor | Acetohydroxamic acid derivatives and pharmaceutical compositions thereof |
| DE2613697A1 (de) * | 1976-03-31 | 1977-10-13 | Hoechst Ag | Herbizide mittel |
| GB1517603A (en) * | 1976-04-02 | 1978-07-12 | Lafon Labor | Esters of 2-(4-(4-chlorobenzoyl)-phenoxy)-2-methyl-propionic acid with bis-(hydroxyalkylthio)-alkanes |
| GB1571829A (en) | 1976-04-06 | 1980-07-23 | Lafon Labor | Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds |
| DE2804576A1 (de) * | 1977-02-15 | 1978-08-17 | Lafon Labor | Phenylamidin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen |
| CA1106403A (en) * | 1977-04-29 | 1981-08-04 | Victor Lafon | Process for preparing (3,4-dichlorophenyl-sulphinyl)- acetamidoxime and its addition salts |
| DE2861187D1 (en) * | 1977-07-07 | 1981-12-24 | Ciba Geigy Ag | Phenoxy-phenylsulfinyl-and-sulfonylalkanecarboxylic acid derivatives, method for their preparation and their use as herbicides and plant growth regulators. |
| JPS5484575A (en) * | 1977-10-26 | 1979-07-05 | Wellcome Found | Imidazoline compound*its manufacture and insecticide composition |
| DK516778A (da) * | 1977-11-28 | 1979-05-29 | Hoffmann La Roche | Oximestere |
| US4302565A (en) * | 1978-03-31 | 1981-11-24 | Union Carbide Corporation | Impregnated polymerization catalyst, process for preparing, and use for ethylene copolymerization |
| FR2428436A1 (fr) * | 1978-06-16 | 1980-01-11 | Oreal | Nouvelles compositions cosmetiques pour le traitement de l'etat gras des cheveux et de la peau, composes nouveaux et leur procede de preparation |
| US4539404A (en) * | 1980-06-19 | 1985-09-03 | Petrolite Corporation | Pyrimidines containing sulfur and amino groups as corrosion inhibitors |
| US4616085A (en) * | 1980-06-19 | 1986-10-07 | Petrolite Corporation | Thioethers of imidazolines |
| US4415591A (en) * | 1981-06-04 | 1983-11-15 | Georgia Tech Research Institute | Use of aminoalkyl phenyl sulfide derivatives for the treatment of hypertension |
| FR2528041A1 (fr) * | 1982-06-04 | 1983-12-09 | Lafon Labor | Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique |
| US4642348A (en) * | 1984-04-10 | 1987-02-10 | A. H. Robins Company, Incorporated | N-(amino)alkyl)-1-pyrrolidine, 1-piperidine and 1-homopiperidinecarboxamides (and thiocarboxamides) with sulfur linked substitution in the 2, 3 or 4-positions |
| DE3508665A1 (de) * | 1985-03-12 | 1986-09-18 | Hoechst Ag, 6230 Frankfurt | Heterocyclische sulfide und ihre anwendung als immunmodulatoren |
| GB8531839D0 (en) * | 1985-12-30 | 1986-02-05 | Wellcome Found | Aryl derivatives |
| JPS61187492U (enExample) * | 1986-01-09 | 1986-11-21 | ||
| US4906667A (en) * | 1986-07-30 | 1990-03-06 | E. R. Squibb & Sons, Inc. | Phenyl hydroxamic acids including a hetero-containing substituent |
| JPH02248756A (ja) * | 1989-03-22 | 1990-10-04 | Honda Motor Co Ltd | ディファレンシャル装置におけるオイルポンプの圧油洩れ逃がし構造 |
| JPH047997U (enExample) * | 1990-05-11 | 1992-01-24 | ||
| EP0994104A4 (en) * | 1996-06-27 | 2001-09-12 | Ono Pharmaceutical Co | ARYL SULFIDE, SULFOXIDE AND SULPHONE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT |
| US6300514B1 (en) | 1997-06-25 | 2001-10-09 | Ono Pharmaceutical Co., Ltd. | Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient |
| US6693517B2 (en) | 2000-04-21 | 2004-02-17 | Donnelly Corporation | Vehicle mirror assembly communicating wirelessly with vehicle accessories and occupants |
| JP3056215B1 (ja) | 1999-05-25 | 2000-06-26 | ファナック株式会社 | 射出成形機の計量制御装置 |
| JP4518637B2 (ja) * | 2000-07-07 | 2010-08-04 | 住友精化株式会社 | ２−（メチルスルホニル）エチルアミンの製造方法 |
| US7581859B2 (en) | 2005-09-14 | 2009-09-01 | Donnelly Corp. | Display device for exterior rearview mirror |
| EP1363810B1 (en) | 2001-01-23 | 2007-05-30 | Donnelly Corporation | Improved vehicular lighting system |
| JP4761096B2 (ja) * | 2001-03-30 | 2011-08-31 | Ｄｉｃ株式会社 | 硫化ヒドロキシ脂肪酸二量体及びその塩の製造方法 |
| ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| GB0226855D0 (en) * | 2002-11-18 | 2002-12-24 | Queen Mary & Westfield College | Histone deacetylase inhibitors |
| ITRM20020629A1 (it) * | 2002-12-19 | 2004-06-20 | Sigma Tau Ind Farmaceuti | Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante. |
| GB0620823D0 (en) * | 2006-10-19 | 2006-11-29 | Univ London | Histone deacetylase inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6406688A (enExample) * | 1964-06-05 | 1965-12-06 | ||
| US3625968A (en) * | 1967-01-12 | 1971-12-07 | Basf Ag | Production of tetrahydro-1,2,4-oxadiazine-3,5-diones |
| DE1957706C3 (de) * | 1968-11-18 | 1978-06-29 | Pfizer Corp., Colon (Panama) | Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis |
| US3703542A (en) * | 1969-11-05 | 1972-11-21 | American Home Prod | Hydroxamic acid derivatives of 1-amino-cyclohexanecarboxylic acid |
| US3789072A (en) * | 1970-04-22 | 1974-01-29 | Squibb & Sons Inc | Carboxamides |
| BE788805A (fr) * | 1971-09-22 | 1973-01-02 | Lafon Victor | Nouveaux derives antalgiques de la serie des arylamines soufrees |
| JPS523361B2 (enExample) * | 1972-03-14 | 1977-01-27 | ||
| US3821289A (en) * | 1972-07-03 | 1974-06-28 | Rorer Inc William H | Tetrahydronaphthylalkanoic acids and their derivatives |
| US3883548A (en) * | 1972-12-06 | 1975-05-13 | Searle & Co | 3-Arylthioalkyl-4-optionally substituted sydnones |
-
1975
- 1975-09-08 FR FR7527484A patent/FR2285867A1/fr active Granted
- 1975-09-08 FR FR7527483A patent/FR2285859A1/fr active Granted
- 1975-09-11 FR FR7527929A patent/FR2285860A1/fr active Granted
- 1975-09-11 CH CH1177075A patent/CH602618A5/xx not_active IP Right Cessation
- 1975-09-15 CH CH1190475A patent/CH603570A5/xx not_active IP Right Cessation
- 1975-09-19 BE BE2054571A patent/BE833580A/xx not_active IP Right Cessation
- 1975-09-22 IE IE2073/75A patent/IE41724B1/en unknown
- 1975-09-22 IE IE2072/75A patent/IE41849B1/en unknown
- 1975-09-22 IE IE2071/75A patent/IE42447B1/en unknown
- 1975-09-23 CA CA236,204A patent/CA1040206A/en not_active Expired
- 1975-09-23 CA CA236,206A patent/CA1073925A/en not_active Expired
- 1975-09-26 BE BE2054585A patent/BE833843A/xx not_active IP Right Cessation
- 1975-09-27 DE DE2543252A patent/DE2543252C2/de not_active Expired
- 1975-09-27 DE DE19752543249 patent/DE2543249A1/de not_active Withdrawn
- 1975-09-27 DE DE19752543184 patent/DE2543184A1/de active Granted
- 1975-09-29 BE BE2054591A patent/BE833928A/xx not_active IP Right Cessation
- 1975-09-29 US US05/617,664 patent/US4065584A/en not_active Expired - Lifetime
- 1975-09-29 BE BE2054590A patent/BE833927A/xx not_active IP Right Cessation
- 1975-09-29 US US05/617,665 patent/US4013776A/en not_active Expired - Lifetime
- 1975-09-30 JP JP50117346A patent/JPS591258B2/ja not_active Expired
- 1975-09-30 CH CH1266775A patent/CH611600A5/xx not_active IP Right Cessation
- 1975-09-30 JP JP50117347A patent/JPS51125228A/ja active Granted
- 1975-09-30 JP JP50117344A patent/JPS51125237A/ja active Pending
- 1975-09-30 JP JP50117345A patent/JPS5820954B2/ja not_active Expired
-
1984
- 1984-06-07 JP JP59115620A patent/JPS6034935A/ja active Granted
- 1984-06-07 JP JP59115619A patent/JPS6110524A/ja active Granted
- 1984-06-07 JP JP59115621A patent/JPS6034939A/ja active Pending
- 1984-07-07 JP JP59139795A patent/JPS60231628A/ja active Pending
- 1984-07-07 JP JP59139796A patent/JPS60248656A/ja active Pending
- 1984-07-07 JP JP59139794A patent/JPS60231648A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE41724B1 (en) | Diphenylsulphoxide derivatives | |
| US3385886A (en) | Phenyl propionic acids | |
| HU198906B (en) | Process for production of cyclodextrin inclusion compounds of carbocyclin derivatives and medical compositions containing them | |
| JPH11500406A (ja) | アセトアミド誘導体類及び食作用挙動モディファイアー | |
| US3642785A (en) | Indenyl-3-aliphatic amines | |
| IE49902B1 (en) | 4-substituted-3-hydroxy-3-pyrroline-2,5-dione compounds,process for their preparation and pharmaceutical compositions containing the same | |
| IE47333B1 (en) | New phenylacetic acid derivatives | |
| GB2144123A (en) | Leukotriene antagonists | |
| ZA200200516B (en) | New selective retinoid agonists. | |
| US4221919A (en) | Antiinflammatory substituted phenylacetic acids | |
| JPH03128343A (ja) | 改良治療特性を有する抗炎症薬の新規亜鉛誘導体 | |
| US3457300A (en) | Acetic acid type compounds | |
| JPH059424B2 (enExample) | ||
| EP0005559B1 (de) | Phenylaminothiophenessigsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| JPH0449533B2 (enExample) | ||
| US3773936A (en) | Method of treating inflammation with substituted anilino salicylic acids | |
| JPS5982367A (ja) | ６−置換キノリン−５，８−キノン類 | |
| CH563364A5 (enExample) | ||
| US3657431A (en) | Treating of inflammation with substituted phenylthiosalicylic acids | |
| HU201521B (en) | Process for producing benzenethio or benzylsulfonyl derivatives with leukotriene antagonist activity and pharmaceutical compositions comprising same | |
| JPS6054285B2 (ja) | シクロヘキサン誘導体を含有する医薬 | |
| US3631167A (en) | 3-indenylmethyltetrazoles | |
| DE68907329T2 (de) | Leukotrien-Antagonisten. | |
| AU726083B2 (en) | New forms of organic salts of N'N-diacetylcystine | |
| US4156011A (en) | Sulphur- and oxygen-containing diaryl compounds |